Report for 2024 on the results from the monitoring of residues of veterinary medicinal products in live animals and animal products

Abstract The report summarises the monitoring data collected in 2024 on the presence of residues of veterinary medicinal products and certain substances in live animals and animal products in the EU Member States, Iceland and Norway. A total of 493,664 samples were reported to the European Commission. A total of 266,477 samples were reported in accordance with the specifications of the national risk‐based control plan for production in the Member States; 10,165 were samples collected in conformity with the specifications of the national randomised surveillance plan for production in the Member States; and 6061 samples were collected in conformity with the specifications of the national risk‐based control plan for third‐country import. Additionally, 9013 suspect samples were reported in 2024 as follow‐up of non‐compliant results and 201,948 samples were collected in the framework of other programmes developed under the national legislation. The majority of countries fulfilled the requirements for sampling frequency laid down in Commission Implementing Regulation 2022/1646.